Trauma Injury clinical trials at UC Health
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
Trauma is the leading cause of death and disability in children in the United States. The objective of this study is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children with hemorrhagic brain and/or torso injuries. A response curve will be generated to evaluate the efficacy of TXA across different levels of fibrinolysis.
at UC Davis